Canadian Stock Trader

A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout

Written by

in

Issued on behalf of Helus Pharma (Nasdaq: HELP) 

Issued on behalf of Helus Pharma (Nasdaq: HELP)

Originally published via Source Article.

More posts